SCHEDULE: Armistice Capital Discloses 4.99% Stake in Inspire Veterinary

Armistice Capital, LLC and Steven Boyd have disclosed a 4.99% beneficial ownership stake in Inspire Veterinary Partners, Inc. Class A Common Stock.

Summary

• Armistice Capital, LLC and Steven Boyd, as Reporting Persons, filed an Amendment No. 2 to Schedule 13G for Inspire Veterinary Partners, Inc.
• The Reporting Persons collectively beneficially own 189,562 shares of Inspire Veterinary Partners, Inc. Class A Common Stock.
• This ownership represents 4.99% of the issuer's Class A Common Stock.
• Armistice Capital, LLC, as the investment manager for Armistice Capital Master Fund Ltd., exercises shared voting and dispositive power over these securities.
• Steven Boyd, as the managing member of Armistice Capital, is also deemed to beneficially own the shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership, providing factual information without expressing positive or negative sentiment regarding the issuer's performance or prospects.

Industry Context

This filing reflects a passive investment by an institutional investor in the veterinary services sector, a growing industry driven by increased pet ownership and spending on pet healthcare. Such disclosures provide transparency on significant ownership stakes within the market.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, potentially influencing market perception of the stock.

Key Dates

Keywords

Inspire Veterinary Partners, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Class A Common Stock, Investment Management, Equity Stake, SEC Filing